anti-eno1 Search Results


  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 91
    StressMarq inhibitory site tyr44
    Inhibitory Site Tyr44, supplied by StressMarq, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/inhibitory site tyr44/product/StressMarq
    Average 91 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    inhibitory site tyr44 - by Bioz Stars, 2023-09
    91/100 stars
      Buy from Supplier

    86
    Abcam anti eno1
    <t>ENO1</t> expression of pancreatic cancer cell lines. A, Total expression level of ENO1 protein in MiaPaCa‐2 and CFPAC‐1 cells detected by Western blotting. B, Representative images showed cell‐surface expression of ENO1, which was analysed by flow cytometry in MiaPaCa‐2 and CFPAC‐1 cells. C, Subcellular expression of ENO1 was detected by immunofluorescence analysis in MiaPaCa‐2 and CFPAC‐1 cells. Results were achieved from representative experiments in triplicate
    Anti Eno1, supplied by Abcam, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti eno1/product/Abcam
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti eno1 - by Bioz Stars, 2023-09
    86/100 stars
      Buy from Supplier

    86
    Millipore anti eno1
    100 μ g CII was injected to DBA/1 mice at day 0 in CFA, a boost was performed 21 days later in IFA. Recombinant <t>enolase</t> <t>(ENO1)</t> or control (BSA) was injected subcutaneously one day before the first immunization with CII. For <t>ENO1,</t> two doses were tested (10 μ g = ENO1 10 μ g (n = 10) and 100 μ g = ENO1 100 μ g (n = 10)). For control mice (n = 10), BSA (100 μ g) was injected in the same buffer as the one used for ENO1 buffer. Clinical status was evaluated by global score (A), articular score (B), weight variation (C) and ankle thickness (D). Bars show the mean ± SEM; * = p < 0.05; ** = p < 0.01 by 2way ANOVA and Bonferroni post-test.
    Anti Eno1, supplied by Millipore, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti eno1/product/Millipore
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti eno1 - by Bioz Stars, 2023-09
    86/100 stars
      Buy from Supplier

    Image Search Results


    ENO1 expression of pancreatic cancer cell lines. A, Total expression level of ENO1 protein in MiaPaCa‐2 and CFPAC‐1 cells detected by Western blotting. B, Representative images showed cell‐surface expression of ENO1, which was analysed by flow cytometry in MiaPaCa‐2 and CFPAC‐1 cells. C, Subcellular expression of ENO1 was detected by immunofluorescence analysis in MiaPaCa‐2 and CFPAC‐1 cells. Results were achieved from representative experiments in triplicate

    Journal: Journal of Cellular and Molecular Medicine

    Article Title: ENO1‐targeted superparamagnetic iron oxide nanoparticles for detecting pancreatic cancer by magnetic resonance imaging

    doi: 10.1111/jcmm.15237

    Figure Lengend Snippet: ENO1 expression of pancreatic cancer cell lines. A, Total expression level of ENO1 protein in MiaPaCa‐2 and CFPAC‐1 cells detected by Western blotting. B, Representative images showed cell‐surface expression of ENO1, which was analysed by flow cytometry in MiaPaCa‐2 and CFPAC‐1 cells. C, Subcellular expression of ENO1 was detected by immunofluorescence analysis in MiaPaCa‐2 and CFPAC‐1 cells. Results were achieved from representative experiments in triplicate

    Article Snippet: To determine the cellular location of ENO1 protein in CFPAC‐1 and MiaPaCa‐2 cells, PDAC cells were incubated with primary antibody, and anti‐ENO1 (Abcam) diluted in 1% bovine serum albumin (BSA) (1:200) overnight at 4°C.

    Techniques: Expressing, Western Blot, Flow Cytometry, Immunofluorescence

    Characterization of ENO1‐Dex‐g‐PCL/SPIO nanoparticles. A and B, ENO1‐Dex‐g‐PCL/SPIO nanoparticles had an average total size of 30 nm. C, The nanoparticles were detected by Fourier transform infrared spectroscopy, and the characteristic C = O absorption peak demonstrated that ENO1 antibody was connected to the SPIO surface. D, X‐ray diffractometry indicated the sample was mainly consisted of Fe 3 O 4 with complete crystal structure. E, Prussian blue staining showed more blue‐stained particles incubated with ENO1‐SPIO in CFPAC‐1 cells compared with SPIO. F, The hysteresis curve demonstrated that the nanoparticles had an appropriate property of superparamagnetism, and significantly decreases of T2 and T2* relaxation time were detected at different iron concentrations. Results were achieved from representative experiments in triplicate

    Journal: Journal of Cellular and Molecular Medicine

    Article Title: ENO1‐targeted superparamagnetic iron oxide nanoparticles for detecting pancreatic cancer by magnetic resonance imaging

    doi: 10.1111/jcmm.15237

    Figure Lengend Snippet: Characterization of ENO1‐Dex‐g‐PCL/SPIO nanoparticles. A and B, ENO1‐Dex‐g‐PCL/SPIO nanoparticles had an average total size of 30 nm. C, The nanoparticles were detected by Fourier transform infrared spectroscopy, and the characteristic C = O absorption peak demonstrated that ENO1 antibody was connected to the SPIO surface. D, X‐ray diffractometry indicated the sample was mainly consisted of Fe 3 O 4 with complete crystal structure. E, Prussian blue staining showed more blue‐stained particles incubated with ENO1‐SPIO in CFPAC‐1 cells compared with SPIO. F, The hysteresis curve demonstrated that the nanoparticles had an appropriate property of superparamagnetism, and significantly decreases of T2 and T2* relaxation time were detected at different iron concentrations. Results were achieved from representative experiments in triplicate

    Article Snippet: To determine the cellular location of ENO1 protein in CFPAC‐1 and MiaPaCa‐2 cells, PDAC cells were incubated with primary antibody, and anti‐ENO1 (Abcam) diluted in 1% bovine serum albumin (BSA) (1:200) overnight at 4°C.

    Techniques: Spectroscopy, Staining, Incubation

    In vitro MRI of ENO1‐Dex‐g‐PCL/SPIO nanoparticles. A, MRI of ENO1‐Dex‐g‐PCL/SPIO nanoparticles in cultured CFPAC‐1 and MiaPaCa‐2 cells. B, Compared with SPIO group, the T2 and T2* values of CFPAC‐1 cells were notably decreased, which were incubated with ENO1‐SPIO. C, The R2 and R2* values of CFPAC‐1 cells were notably increased in ENO1‐SPIO group compared with SPIO group. Results were achieved from representative experiments in triplicate and were shown as mean ± standard deviation (SD). * P < .05, ** P < .01

    Journal: Journal of Cellular and Molecular Medicine

    Article Title: ENO1‐targeted superparamagnetic iron oxide nanoparticles for detecting pancreatic cancer by magnetic resonance imaging

    doi: 10.1111/jcmm.15237

    Figure Lengend Snippet: In vitro MRI of ENO1‐Dex‐g‐PCL/SPIO nanoparticles. A, MRI of ENO1‐Dex‐g‐PCL/SPIO nanoparticles in cultured CFPAC‐1 and MiaPaCa‐2 cells. B, Compared with SPIO group, the T2 and T2* values of CFPAC‐1 cells were notably decreased, which were incubated with ENO1‐SPIO. C, The R2 and R2* values of CFPAC‐1 cells were notably increased in ENO1‐SPIO group compared with SPIO group. Results were achieved from representative experiments in triplicate and were shown as mean ± standard deviation (SD). * P < .05, ** P < .01

    Article Snippet: To determine the cellular location of ENO1 protein in CFPAC‐1 and MiaPaCa‐2 cells, PDAC cells were incubated with primary antibody, and anti‐ENO1 (Abcam) diluted in 1% bovine serum albumin (BSA) (1:200) overnight at 4°C.

    Techniques: In Vitro, Cell Culture, Incubation, Standard Deviation

    Detection of pancreatic tumour by in vivo MRI of ENO1‐Dex‐g‐PCL/SPIO nanoparticles. A, MRI of ENO1‐Dex‐g‐PCL/SPIO nanoparticles in a pancreatic cancer xenograft model. B, Compared with PBS control group and SPIO group, the T2 signal intensity of tumour tissue significantly decreased, and the tumour gradually darkened over time, in which the peak of enhancement was at 24 h in ENO1‐SPIO group. C, IHC staining (40×) of the pancreatic tumour tissues 24 h after injection with ENO1‐SPIO nanoparticles. D, Prussian blue staining (40×) of the pancreatic tumour tissues 24 h after injection with ENO1‐SPIO or SPIO. More positive iron particles were found in ENO1‐SPIO group. Results were achieved from representative experiments in triplicate and were shown as mean ± standard deviation (SD). * P < .05, ** P < .01

    Journal: Journal of Cellular and Molecular Medicine

    Article Title: ENO1‐targeted superparamagnetic iron oxide nanoparticles for detecting pancreatic cancer by magnetic resonance imaging

    doi: 10.1111/jcmm.15237

    Figure Lengend Snippet: Detection of pancreatic tumour by in vivo MRI of ENO1‐Dex‐g‐PCL/SPIO nanoparticles. A, MRI of ENO1‐Dex‐g‐PCL/SPIO nanoparticles in a pancreatic cancer xenograft model. B, Compared with PBS control group and SPIO group, the T2 signal intensity of tumour tissue significantly decreased, and the tumour gradually darkened over time, in which the peak of enhancement was at 24 h in ENO1‐SPIO group. C, IHC staining (40×) of the pancreatic tumour tissues 24 h after injection with ENO1‐SPIO nanoparticles. D, Prussian blue staining (40×) of the pancreatic tumour tissues 24 h after injection with ENO1‐SPIO or SPIO. More positive iron particles were found in ENO1‐SPIO group. Results were achieved from representative experiments in triplicate and were shown as mean ± standard deviation (SD). * P < .05, ** P < .01

    Article Snippet: To determine the cellular location of ENO1 protein in CFPAC‐1 and MiaPaCa‐2 cells, PDAC cells were incubated with primary antibody, and anti‐ENO1 (Abcam) diluted in 1% bovine serum albumin (BSA) (1:200) overnight at 4°C.

    Techniques: In Vivo, Immunohistochemistry, Injection, Staining, Standard Deviation

    100 μ g CII was injected to DBA/1 mice at day 0 in CFA, a boost was performed 21 days later in IFA. Recombinant enolase (ENO1) or control (BSA) was injected subcutaneously one day before the first immunization with CII. For ENO1, two doses were tested (10 μ g = ENO1 10 μ g (n = 10) and 100 μ g = ENO1 100 μ g (n = 10)). For control mice (n = 10), BSA (100 μ g) was injected in the same buffer as the one used for ENO1 buffer. Clinical status was evaluated by global score (A), articular score (B), weight variation (C) and ankle thickness (D). Bars show the mean ± SEM; * = p < 0.05; ** = p < 0.01 by 2way ANOVA and Bonferroni post-test.

    Journal: PLoS ONE

    Article Title: Prophylactic Injection of Recombinant Alpha-Enolase Reduces Arthritis Severity in the Collagen-Induced Arthritis Mice Model

    doi: 10.1371/journal.pone.0136359

    Figure Lengend Snippet: 100 μ g CII was injected to DBA/1 mice at day 0 in CFA, a boost was performed 21 days later in IFA. Recombinant enolase (ENO1) or control (BSA) was injected subcutaneously one day before the first immunization with CII. For ENO1, two doses were tested (10 μ g = ENO1 10 μ g (n = 10) and 100 μ g = ENO1 100 μ g (n = 10)). For control mice (n = 10), BSA (100 μ g) was injected in the same buffer as the one used for ENO1 buffer. Clinical status was evaluated by global score (A), articular score (B), weight variation (C) and ankle thickness (D). Bars show the mean ± SEM; * = p < 0.05; ** = p < 0.01 by 2way ANOVA and Bonferroni post-test.

    Article Snippet: Then, we used mouse anti-IgG HRP-conjugated antibodies (LifeTechnologies) for 1 h. TMB (Sigma) was used to reveal the presence of anti-ENO1.

    Techniques: Injection, Recombinant

    Serum levels of anti-ENO1 (A), anti-pEP1 (C) and anti-collagen II (B and D) antibodies in control or treated mice were measured by ELISA. AU is considered as Arbitrary Units. Bars represent the mean ± SEM; * = p < 0.05; ** = p < 0.01, by 2way ANOVA and Bonferroni post-test (A and B); * = p < 0.05, by Mann-Withney (C and D).

    Journal: PLoS ONE

    Article Title: Prophylactic Injection of Recombinant Alpha-Enolase Reduces Arthritis Severity in the Collagen-Induced Arthritis Mice Model

    doi: 10.1371/journal.pone.0136359

    Figure Lengend Snippet: Serum levels of anti-ENO1 (A), anti-pEP1 (C) and anti-collagen II (B and D) antibodies in control or treated mice were measured by ELISA. AU is considered as Arbitrary Units. Bars represent the mean ± SEM; * = p < 0.05; ** = p < 0.01, by 2way ANOVA and Bonferroni post-test (A and B); * = p < 0.05, by Mann-Withney (C and D).

    Article Snippet: Then, we used mouse anti-IgG HRP-conjugated antibodies (LifeTechnologies) for 1 h. TMB (Sigma) was used to reveal the presence of anti-ENO1.

    Techniques: Enzyme-linked Immunosorbent Assay

    Serum levels of IL-4 (A and C) and IL-6 (B and D) in ENO1 treated mice (A-B) and pEP1 treated mice (C-D), compared to control mice, were measured by Luminex. Bars represent the mean ± SEM. Statistical analysis used are 2way ANOVA (A and B) or Mann-Withney (C and D).

    Journal: PLoS ONE

    Article Title: Prophylactic Injection of Recombinant Alpha-Enolase Reduces Arthritis Severity in the Collagen-Induced Arthritis Mice Model

    doi: 10.1371/journal.pone.0136359

    Figure Lengend Snippet: Serum levels of IL-4 (A and C) and IL-6 (B and D) in ENO1 treated mice (A-B) and pEP1 treated mice (C-D), compared to control mice, were measured by Luminex. Bars represent the mean ± SEM. Statistical analysis used are 2way ANOVA (A and B) or Mann-Withney (C and D).

    Article Snippet: Then, we used mouse anti-IgG HRP-conjugated antibodies (LifeTechnologies) for 1 h. TMB (Sigma) was used to reveal the presence of anti-ENO1.

    Techniques: Luminex

    Histological analyses were performed on CIA mice receiving prophylactic injection of ENO1 (A) or pEP1 (B) and were compared to those carried out in controls. Both hind and anterior paws were dissected and fixed for 48h in 10% phosphate-buffered formaldehyde 80 days after CII immunization. Different scores were assessed: inflammation (Infl), synovitis (Syno), cartilage resorption (Cart Res) and bone erosion (Bone Ero). In C, anterior paws of control mice (left) and anterior paws of CIA mice who received ENO1 100 μ g in a prophylactic way (right) were represented. 1: Synovial tissue hypertrophy; 2: Newly formed cartilage; 3: Fibrin deposit; 4: Cartilage resorption. Histograms show mean ± SEM; * = p < 0.05; ** = p < 0.01 by t-tests.

    Journal: PLoS ONE

    Article Title: Prophylactic Injection of Recombinant Alpha-Enolase Reduces Arthritis Severity in the Collagen-Induced Arthritis Mice Model

    doi: 10.1371/journal.pone.0136359

    Figure Lengend Snippet: Histological analyses were performed on CIA mice receiving prophylactic injection of ENO1 (A) or pEP1 (B) and were compared to those carried out in controls. Both hind and anterior paws were dissected and fixed for 48h in 10% phosphate-buffered formaldehyde 80 days after CII immunization. Different scores were assessed: inflammation (Infl), synovitis (Syno), cartilage resorption (Cart Res) and bone erosion (Bone Ero). In C, anterior paws of control mice (left) and anterior paws of CIA mice who received ENO1 100 μ g in a prophylactic way (right) were represented. 1: Synovial tissue hypertrophy; 2: Newly formed cartilage; 3: Fibrin deposit; 4: Cartilage resorption. Histograms show mean ± SEM; * = p < 0.05; ** = p < 0.01 by t-tests.

    Article Snippet: Then, we used mouse anti-IgG HRP-conjugated antibodies (LifeTechnologies) for 1 h. TMB (Sigma) was used to reveal the presence of anti-ENO1.

    Techniques: Injection

    Correlation between clinical and histological scores for experiments based on prophylactic injection of  ENO1.  Correlations between histological findings and clinical data were studied using Spearman’s rank correlation coefficient. Data are represented as Rs and p value.

    Journal: PLoS ONE

    Article Title: Prophylactic Injection of Recombinant Alpha-Enolase Reduces Arthritis Severity in the Collagen-Induced Arthritis Mice Model

    doi: 10.1371/journal.pone.0136359

    Figure Lengend Snippet: Correlation between clinical and histological scores for experiments based on prophylactic injection of ENO1. Correlations between histological findings and clinical data were studied using Spearman’s rank correlation coefficient. Data are represented as Rs and p value.

    Article Snippet: Then, we used mouse anti-IgG HRP-conjugated antibodies (LifeTechnologies) for 1 h. TMB (Sigma) was used to reveal the presence of anti-ENO1.

    Techniques: Injection